Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

		Cancer Friends Network > Types of Cancer > Extrahepatic Bile Duct Cancer
Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-04-2012, 08:14 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange announced today the successful results of the Phase 1/2 study of its drug candidate CF102 in the treatment of hepatocellular carcinoma.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 09:46 AM.

CancerFriends.net